HUM

Humana
D

HUM

Arincen41/100B

Humana return on equity (ROE)

Humana's return on equity is 6.60%: net income of 1.24B USD over the last twelve months on shareholders' equity of 18.83B USD.

Today
6.60%
Average, 5 years
12.73%
Low, 5 years
6.05%
High, 5 years
20.30%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 1.24B ÷ 18.83B = 6.60%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

What drives Humana's return on equity?

Net margin
0.9%
profit on each dollar of sales
Asset turnover
2.66×
sales on each dollar of assets
Equity multiplier
2.76×
assets on each dollar of equity
Return on equity
6.7%
FY2025
  • FY20250.9% × 2.66 × 2.76 = 6.7%
  • FY20241.0% × 2.54 × 2.83 = 7.4%
  • FY20232.3% × 2.27 × 2.88 = 15.3%
  • FY20223.0% × 2.13 × 2.86 = 18.3%
  • FY20213.5% × 1.87 × 2.78 = 18.2%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today6.60%1.24B18.83B
FY202531 Dec 20256.81%1.20B17.66B
FY202431 Dec 20247.41%1.21B16.38B
FY202331 Dec 202315.31%2.49B16.26B
FY202231 Dec 202218.30%2.80B15.31B
FY202131 Dec 202118.25%2.93B16.08B
FY202031 Dec 202024.53%3.37B13.73B
FY201931 Dec 201922.49%2.71B12.04B
FY201831 Dec 201816.56%1.68B10.16B
FY201731 Dec 201724.87%2.45B9.84B
FY201631 Dec 20165.75%614.00M10.69B
FY201531 Dec 201512.33%1.28B10.35B
FY201431 Dec 201411.89%1.15B9.65B
FY201331 Dec 201313.21%1.23B9.32B
FY201231 Dec 201213.81%1.22B8.85B
FY201131 Dec 201117.60%1.42B8.06B
FY201031 Dec 201015.88%1.10B6.92B
FY200931 Dec 200918.00%1.04B5.78B
FY200831 Dec 200814.52%647.15M4.46B
FY200731 Dec 200720.69%833.68M4.03B
FY200631 Dec 200615.96%487.42M3.05B
FY200531 Dec 200512.47%308.48M2.47B
FY200431 Dec 200413.40%280.01M2.09B
FY200331 Dec 200312.47%228.93M1.84B
FY200231 Dec 20028.89%142.76M1.61B
FY200131 Dec 20017.77%117.17M1.51B
FY200031 Dec 20006.62%90.00M1.36B
FY199931 Dec 1999-31.07%-394.00M1.27B
FY199831 Dec 19987.64%129.00M1.69B
FY199731 Dec 199711.53%173.00M1.50B
FY199631 Dec 19960.93%12.00M1.29B
FY199531 Dec 199514.76%190.00M1.29B
FY199431 Dec 199416.64%176.00M1.06B
FY199331 Dec 199310.01%89.00M889.00M
FY199231 Aug 19923.56%71.70M2.02B
FY199131 Aug 199117.67%355.00M2.01B
FY199031 Aug 199018.19%318.20M1.75B

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Dividend yield,Debt to equity,Current ratio,All ratios

Common questions about Humana's ROE

Source: Financial Modeling Prep